Maryam Mohammadi-Khanaposhtani
机构: Babol University of Medical Sciences
每年引用次数
引用次数
引用: 9,242
H-指数: 30
I10-指数 : 65
出版物: 112
The synthesis of 1,2,4-benzotriazines
G. Mohammadi Ziarani , M. Mostofi , P. Gholamzadeh , M. Mohammadi-Khanaposhtani
Arkivoc 2019 ( 1) 41 -105
1
2019
Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors.
Saeed Bahadorikhalili , Massoud Amanlou , Bagher Larijani , Mehdi Asadi
Scientific Reports 11 ( 1) 10607
2021
Synthesis and biological evaluation of a new series of benzofuran-1,3,4-oxadiazole containing 1,2,3-triazole-acetamides as potential α-glucosidase inhibitors.
Fahimeh Abedinifar , Maryam Mohammadi‐Khanaposhtani , Nafise Asemanipoor , Somayeh Mojtabavi
Journal of Biochemical and Molecular Toxicology 35 ( 4)
2021
Design, synthesis, biological evaluation, and molecular dynamics of novel cholinesterase inhibitors as anti‐Alzheimer's agents
Reza Shamsimeymandi , Yaghoub Pourshojaei , Khalil Eskandari , Maryam Mohammadi‐Khanaposhtani
Archiv Der Pharmazie 352 ( 7) 1800352
17
2019
A new series of Schiff base derivatives bearing 1,2,3‐triazole: Design, synthesis, molecular docking, and α‐glucosidase inhibition
Ensieh Nasli‐Esfahani , Maryam Mohammadi‐Khanaposhtani , Sepideh Rezaei , Yaghoub Sarrafi
Archiv Der Pharmazie 352 ( 8) 1900034
4
2019
Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin-3-carboxamide-N-morpholine Hybrids as New Anti-Alzheimer Agents.
Maliheh Barazandeh Tehrani , Zahra Rezaei , Mehdi Asadi , Hossein Behnammanesh
Chemistry & Biodiversity 16 ( 7)
5
2019
Design, Synthesis, Molecular Docking, and Cholinesterase Inhibitory Potential of Phthalimide-Dithiocarbamate Hybrids as New Agents for Treatment of Alzheimer's Disease.
Mehdi Asadi , Mostafa Ebrahimi , Maryam Mohammadi‐Khanaposhtani , Homa Azizian
Chemistry & Biodiversity 16 ( 11) 1900370
6
2019
Design, synthesis, biological evaluation, and docking study of new acridine‐9‐carboxamide linked to 1,2,3‐triazole derivatives as antidiabetic agents targeting α‐glucosidase
Mohammad S Asgari , Behnam Tahmasebi , Somayeh Mojtabavi , Mohammad A Faramarzi
Journal of Heterocyclic Chemistry 57 ( 12) 4348 -4357
5
2020
New 1,2,3‐triazole–(thio)barbituric acid hybrids as urease inhibitors: Design, synthesis, in vitro urease inhibition, docking study, and molecular dynamic simulation
Mohammad S Asgari , Homa Azizian , Mohammad Nazari Montazer , Maryam Mohammadi‐Khanaposhtani
Archiv Der Pharmazie 353 ( 9) 2000023
21
2020
Synthesis, characterization, molecular docking, and biological activities of coumarin-1,2,3-triazole-acetamide hybrid derivatives.
Nima Sepehri , Maryam Mohammadi‐Khanaposhtani , Nafise Asemanipoor , Samanesadat Hosseini
Archiv Der Pharmazie 353 ( 10) 2000109
8
2020
Benzoylquinazolinone derivatives as new potential antidiabetic agents: α‐Glucosidase inhibition, kinetic, and docking studies
Maryam Mohammadi‐Khanaposhtani , Hoda Yahyavi , Somaye Imanparast , Fereshte Nazemi Harandi
Journal of The Chinese Chemical Society 67 ( 5) 856 -863
2
2020
Design and synthesis of 2,4‐dioxochroman‐pyridinium‐phenylacetamide derivatives as new anti‐Alzheimer agents: in vitro and in silico studies
Marjan Mollazadeh , Maryam Mohammadi‐Khanaposhtani , Homa Azizian , Afsaneh Zonouzi
Journal of The Chinese Chemical Society 67 ( 10) 1910 -1928
2020
New 4‐phenylpiperazine‐carbodithioate‐N‐phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α‐glucosidase enzymes
Maryam Mohammadi‐Khanaposhtani , Milad Nori , Yousef Valizadeh , Shahrzad Javanshir
Archiv Der Pharmazie 355 ( 5) 2100313 -2100313
14
2022
Design, synthesis, and α‐glucosidase‐inhibitory activity of phenoxy‐biscoumarin–N‐phenylacetamide hybrids
Samira Ansari , Homa Azizian , Keyvan Pedrood , Ali Yavari
Archiv der Pharmazie 354 ( 12) 2100179 -2100179
12
2021
Synthesis, α‐glucosidase Inhibition, in silico Pharmacokinetic, and Docking Studies Of Thieno [2, 3‐b] Quinoline‐Acetamide Derivatives as New Anti‐Diabetic Agents
Maryam Mohammadi‐Khanaposhtani , Milad Noori , Yousef Valizadeh , Navid Dastyafteh
ChemistrySelect 7 ( 44) e202104482 -e202104482
6
2022
Design, synthesis, α‐glucosidase inhibition, pharmacokinetic, and cytotoxic studies of new indole‐carbohydrazide‐phenoxy‐N‐phenylacetamide derivatives
Haleh Hamedifar , Maryam Mohammadi‐Khanaposhtani , Maedeh Sherafati , Milad Noori
Archiv der Pharmazie 356 ( 6) 2200571 -2200571
4
2023
Novel spiro [indene‐1, 2′‐quinazolin]‐4′(3′ H)‐one derivatives as potent anticonvulsant agents: One‐pot synthesis, in vivo biological evaluation, and molecular docking studies
Ali Asghar Mohammadi , Salman Taheri , Sanaz Shisheboran , Reza Ahdenov
Journal of Biochemical and Molecular Toxicology 37 ( 1) e23234 -e23234
3
2023
Design, Synthesis, in Vitro, and in Silico Evaluation of N‐Phenylacetamide‐Oxindole‐Thiosemicarbazide Hybrids as New Potential Tyrosinase Inhibitors
Shahriar Yari Boroujeni , Zahra Haghighijoo , Maryam Mohammadi‐Khanaposhtani , Ali Mosadeghkhah
Chemistry & Biodiversity 19 ( 4) e202100666 -e202100666
1
2022
New phenylthiosemicarbazide‐phenoxy‐1, 2, 3‐triazole‐N‐phenylacetamides as dual inhibitors against α‐glucosidase and PTP‐1B for the treatment of type 2 diabetes
Shirin Ansariashlaghi , Azadeh Fakhrioliaei , Maryam Mohammadi‐Khanaposhtani , Milad Noori
Archiv der Pharmazie e2300517 -e2300517
2024
Rational Design, Synthesis, Docking Simulation, and ADMET Prediction of Novel Barbituric‐hydrazine‐phenoxy‐1, 2, 3‐triazole‐acetamide Derivatives as Potent Urease Inhibitors
Nouraddin Hosseinzadeh , Mohammad Nazari Montazer , Maryam Mohammadi‐Khanaposhtani , Yousef Valizadeh
ChemistrySelect 8 ( 3) e202203297 -e202203297
3
2023